1. First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids.
- Author
-
Luyckx M, Squifflet JL, Jadoul P, Votino R, Dolmans MM, and Donnez J
- Subjects
- Adult, Antineoplastic Agents therapeutic use, Contraceptive Agents therapeutic use, Female, Humans, Leiomyoma pathology, Pilot Projects, Pregnancy, Pregnancy Complications, Neoplastic pathology, Pregnancy Outcome, Treatment Outcome, Uterine Neoplasms pathology, Abortion, Spontaneous diagnosis, Leiomyoma drug therapy, Live Birth, Norpregnadienes therapeutic use, Pregnancy Complications, Neoplastic drug therapy, Uterine Neoplasms drug therapy
- Abstract
Objective: To study the pregnancy rate after ulipristal acetate (UPA) therapy for fibroids., Design: Retrospective analysis of a series of 52 patients prospectively included in the PGL4001 (ulipristal acetate) Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARL) II and III trials., Setting: Academic hospital., Patient(s): Among the 52 patients, 21 wished to conceive upon treatment completion., Intervention(s): None., Main Outcome Measure(s): Pregnancy rate and live birth rate., Result(s): Twenty-one patients attempted to get pregnant, among whom 15 (71%) succeeded, totaling 18 pregnancies. Among these 18 pregnancies, 12 resulted in the birth of 13 healthy babies and 6 ended in early miscarriage. No regrowth of fibroids was observed during pregnancy., Conclusion(s): We report the first series of pregnancies achieved after UPA treatment. Our data confirm a sustained long-term effect after UPA therapy., (Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF